Six investors we surveyed recently told us that the macro environment has had a big impact on dealflow, valuations and M&A in biotech.
As AI pervades biotech, what are investors looking for in 2023? by Anna Heim originally published on TechCrunch
Heartex, the well-funded machine learning data labeling startup, is launching a major update to its platform today that will open up new use cases for its tools by making annotating audio files in the commercial and open source versions of its Label Studio a lot easier for its users. These updates include a new user […]
Heartex’s Label Studio makes labeling audio for ML easier by Frederic Lardinois originally published on TechCrunch
To get a better idea of how AI is affecting biotech in 2022, we asked six investors to tell us what they look for in a biotech startup today.
6 investors discuss why AI is more than just a buzzword in biotech by Anna Heim originally published on TechCrunch
The fight over whether gig workers are independent contractors or employees has been heating up this week on both state and federal levels. The stakes? A once disruptive business model could soon be disrupted itself. On the state level, this week has seen developments in the Proposition 22 saga as companies relying on gig workers […]
The battle over gig worker status is heating up by Rebecca Bellan originally published on TechCrunch
If you’re reading this, I’m willing to bet you probably weren’t arrested this week and are now sitting in a Bahamian jail.
SBF’s handcuffs aren’t loosening up anytime soon by Jacquelyn Melinek originally published on TechCrunch
MedCrypt shared with us the deck it used to raise a $25 million Series B.
Pitch Deck Teardown: MedCrypt’s $25M Series B deck by Haje Jan Kamps originally published on TechCrunch